Anti-proliferative effect of allicin on human hepatoma HepG2 cells.

被引:0
|
作者
Ye, Hailin [1 ]
Ye, Guanxiong [1 ]
Jiang, Jinyan [1 ]
Xu, Xiaoya [1 ]
Wu, Chengjun [1 ]
机构
[1] Lishui Peoples Hosp, Dept Hepatobiliary & Pancreat Surg, Lishui 323000, Zhejiang, Peoples R China
来源
BIOMEDICAL RESEARCH-INDIA | 2016年 / 27卷 / 01期
关键词
Allicin; Supercritical extraction; HepG2; cell;
D O I
暂无
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
To investigate the factors influencing the supercritical CO2 extraction of garlic oil, and to explore the inhibitory effect of allicin on human hepatoma HepG2 cell growth. Appropriate combination of process parameters for supercritical CO2 extraction of garlic oil was identified through orthogonal experiment. Human hepatoma HepG(2) cells were cultured in vitro, and changes in growth of allicin- treated HepG2 cells were determined by MTT assay and flow cytometry. Optimal experimental conditions for supercritical CO2 extraction of garlic oil were extraction pressure of 15 Mpa, extraction duration of 1.5 h, and temperature of 40 degrees C. Cell cycle analysis by MTT assay and flow cytometry showed that allicin had a marked inhibitory effect on growth of HepG2 cells, which increased with increasing allicin concentration and treatment time. Under inverted microscope, the allicin- treated HepG2 cells exhibited reduced intercellular junction and cellular shrinkage. With increasing concentration of allicin, changes in the intercellular junction and cellular morphology became increasingly evident. Most cells were detached; chromatins were condensed, compacted and split into clumps; and typical apoptotic characteristics such as apoptotic bodies emerged. Allicin has a certain inhibitory effect on growth of human hepatoma HepG2 cells.
引用
收藏
页码:195 / 198
页数:4
相关论文
共 50 条
  • [21] Anti-Proliferative Effect of Immunosuppressive Drugs on Pancreatic β-Cells.
    Schuetz, Christian
    Lee, Kang Mi
    Machaidze, Zurab
    Smith, Rex Neal
    Deng, Shaoping
    Markmann, James F.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 : 673 - 673
  • [22] The anti-proliferative effects of norcantharidin on human HepG2 cells in cell culture (vol 38, gp 163, 2011)
    Chang, Cheng
    Zhu, Youqing
    Tang, Xiaoyan
    Tao, Wenhui
    MOLECULAR BIOLOGY REPORTS, 2012, 39 (07) : 7841 - 7841
  • [23] The anti-proliferative effects of norcantharidin on human HepG2 cells in cell culture (vol 38, pg 163, 2011)
    Chang, Cheng
    Zhu, Youqing
    Tang, Xiaoyan
    Tao, Wenhui
    MOLECULAR BIOLOGY REPORTS, 2013, 40 (01) : 739 - 739
  • [24] Anti-hepatoma effect of homologous delivery of doxorubicin by HepG2 cells
    Sun, Lina
    Ma, Baonan
    Yang, Fangzhou
    Zou, Hang
    Guo, Yifei
    Wang, Xiangtao
    Han, Meihua
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2025, 670
  • [25] The procoagulant effect of homocysteine on the human HepG-2 hepatoma cells.
    Phillips, DJ
    Renshaw, M
    Evatt, BL
    Rickles, FR
    Hooper, WC
    BLOOD, 1997, 90 (10) : 3159 - 3159
  • [26] Electrophoretic behaviors of human hepatoma HepG2 cells
    Hsu, Jyh-Ping
    Ku, Ming-Hong
    Yang, Li-Chia
    Lu, Jui-Nan
    Youny, Tai-Horng
    Tseng, Shiojenn
    ELECTROPHORESIS, 2009, 30 (09) : 1531 - 1537
  • [27] Effect of acetaminophen on doxorubicin accumulation and toxicity in hepatoma-derived HepG2 cells.
    Manov, Irena
    Eliaz-Wolkowics, Anat
    Bashenko, Yulia
    Mizrahi, Meital
    Liran, Oded
    Iancu, Theodore C.
    ACTA PHARMACOLOGICA SINICA, 2006, 27 : 64 - 64
  • [28] Anti-proliferative activity of fenretinide in human hepatoma cells in vitro and in vivo
    Shentu, Jianzhong
    Zhang, Bo
    Fan, Lingling
    He, Qioajun
    Yang, Bo
    Chen, Zhi
    ANTI-CANCER DRUGS, 2007, 18 (01) : 47 - 53
  • [29] Anti-proliferative effects of 2′3′-dideoxycytidine in human pancreatic tumor cells.
    Lewis, LD
    Strawbridge, RR
    McQuilkin, SH
    JOURNAL OF INVESTIGATIVE MEDICINE, 1998, 46 (03) : 213A - 213A
  • [30] Transcriptome Analyses of the Anti-Proliferative Effects of 20(S)-Ginsenoside Rh2 on HepG2 Cells
    Zhang, Ji
    Li, Weibo
    Yuan, Qiaoyun
    Zhou, Jing
    Zhang, Jianmei
    Cao, Yufeng
    Fu, Guangbo
    Hu, Weicheng
    FRONTIERS IN PHARMACOLOGY, 2019, 10